IMPRESS leads the way for cancer precision medicine
IMPRESS Norway is a national clinical study starting in 2021...
Author: Ola Myklebost
Defence is the Best Attack: Immuno-Oncology Breakthroughs Virtual event, Worldwide : 16 – 17 February 2021
[et_pb_section admin_label=”section”][et_pb_row admin_label=”row”][/et_pb_row][/et_pb_section]
Contribution of NCGC to PCAWG
[et_pb_section admin_label=”Seksjon” fullwidth=”on” specialty=”off”][et_pb_fullwidth_post_title admin_label=”Fullbreddes innleggstittel” title=”on” meta=”off” author=”on” date=”on”...
NCGC-associated PhD-student corresponds on data sharing in Science
Sorry, this entry is only available in Norsk. For the...
NCGC presents their recommendation to the Minister of Health
[et_pb_section admin_label=”Seksjon” fullwidth=”on” specialty=”off”][et_pb_fullwidth_post_title admin_label=”Fullbreddes innleggstittel” title=”on” meta=”off” author=”on” date=”on”...
Two papers for the NCGC law PhD on the implications of EU privacy rules (GDPR) for health research (impact factor 19)
[et_pb_section admin_label=”Seksjon” fullwidth=”on” specialty=”off”][et_pb_fullwidth_post_title admin_label=”Fullbreddes innleggstittel” title=”on” meta=”off” author=”on” date=”on”...
NCGC receives international attention
As a common project in a national health service, it finds interest in Lancet, Nature and other media.